News

Filter By :

Category

  • All
  • AppleGate Recovery
  • BAART Programs
  • BayMark Health Services
  • Canadian Addiction Treatment Centres
  • Family Recovery Solutions
  • Granite Recovery
  • Health Care Resource Centers
  • Hope For Tomorrow
  • Liberty Bay Recovery Center
  • MedMark Treatment Centers
  • Middlesex Recovery
  • Mt. Sinai
  • Nashville Recovery Suboxone Clinic
  • New Day Recovery
  • Pathfinders Recovery Center
  • Recovery Pathways
  • Recovery Services of New Mexico
  • Riverwood Group
  • San Antonio Recovery Center
  • SpecialCare Hospital Management
  • The Coleman Institute
  • Uncategorized

Date Posted

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Health Services Opens New Treatment Center In California’s Central Valley

Jun 14th 2017

BayMark Health Services announced the opening of a new outpatient, medication-assisted treatment program in Porterville, California, the fifth BAART Programs location in the Southern Central Valley. BAART Porterville will be focused on offering individualized, quality treatment and support services to those struggling with the disease of opiate addiction. BAART Programs...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

BayMark Health Services Announces New Location In El Dorado, Arkansas

Jun 12th 2017

BayMark Health Services is pleased to announce the opening of a new outpatient facility for the treatment of opioid use disorder today as part of their AppleGate Recovery brand. Currently there are AppleGate locations in both Louisiana and Texas. This is the first BayMark clinic to open in Arkansas. AppleGate...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

Dr. Jeffrey Simon of New Jersey Joins The Coleman Institute Network

Apr 25th 2017

Richmond, Virginia (April 25, 2017) – The Coleman Institute, a nationally recognized leader in opioid addiction treatment, is excited to have Jeffrey Simon, MD join our network. Beginning in May, Dr. Simon will be seeing patients in his Cherry Hill, New Jersey offices, offering a full range of treatment services...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

The Coleman Institute Announces New Affiliate in Seattle Washington

Feb 15th 2017

The Coleman Institute, a nationally recognized leader in opioid addiction treatment, is pleased to announce its partnership with Dr. Barbara Mendrey and the North Shore Family Practice near Seattle, Washington. As a new affiliate Dr. Mendrey and her team offer a full range of treatment services including accelerated detox, Naltrexone...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

Baymark Health Services Acquires the Coleman Institute Bringing Expanded treatment Options to Patients Nationwide

Jan 23rd 2017

BayMark Health Services is pleased to announce the recent acquisition of The Coleman Institute, an outpatient detoxification company located in Richmond, VA with 8 affiliated offices nationwide. This is BayMark’s first acquisition of an outpatient detoxification company and represents our continuing commitment to providing a full continuum of treatment services...

Read More

2023 Opioid Use Disorder Treatment Outcomes Report

BayMark, a leading provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), is thrilled to announce the release of its much-anticipated whitepaper, the "2023 Nationwide Opioid Use Disorder Treatment Outcomes Report". This comprehensive study, conducted with one of the largest-ever data sets in the field, delves deep into the efficacy of medication-assisted treatment (MAT). This detailed report, based on an exhaustive analysis of approximately 39,000 patients, offers a trove of knowledge and evidence-based clinical outcomes.

November 27th 2023
Get The Whitepaper

Baymark Health Services Acquires Applegate Recovery

Jan 16th 2017

BayMark Health Services announced today that it has acquired four office-based opioid treatment facilities in Louisiana and Texas. AppleGate Recovery, established in Louisiana in 2008, is a highly successful office-based opioid treatment provider, which has become an operating division of BayMark Health Services. “We are very excited to have the...

Read More
Now Available: BayMark's 2023 Treatment Outcomes ReportGet the Whitepaper